Standard BioTools

Standard BioTools PP&E per Employee

The PP&E per Employee of Standard BioTools (LAB) as of Sep 21, 2026 is 153,046.27 USD. In the previous year, PP&E per Employee was 167,488.43 USD — a change of -8.62% (lower).

PP&E per Employee

153,046.27USD

YoY

-8.62%

Last updated:

PP&E per Employee of Standard BioTools is 2026 153,046.27 USD. PP&E per Employee of Standard BioTools was 2025 167,488.43 USD. It decreases by -8.62% lower compared to the previous year.

The Standard BioTools PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2016
42,480.72 USD
Jan 1, 2017
31,622.11 USD
Jan 1, 2018
22,686.38 USD
Jan 1, 2019
33,203.08 USD
Jan 1, 2020
143,046.27 USD
Jan 1, 2021
167,488.43 USD
Jan 1, 2022
153,046.27 USD
The Standard BioTools PP&E per Employee history
YEARPP&E per EmployeeYoY
153,046.27USD-8.62%
167,488.43USD+17.09%
143,046.27USD+330.82%
33,203.08USD+46.36%
22,686.38USD-28.26%
31,622.11USD-25.56%
42,480.72USD
Access this data via the Eulerpool API

Standard BioTools Stock analysis

What does Standard BioTools do? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Standard BioTools stock

PP&E per Employee of Standard BioTools is 153,046.27 USD in 2026.

PP&E per Employee of Standard BioTools changed from 167,488.43 USD to 153,046.27 USD, representing a -8.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Standard BioTools since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Standard BioTools historically and in real time.

Access this data via the Eulerpool API

Workforce — Standard BioTools

All Key Metrics — Standard BioTools